IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,966 | +10.1% | 1,807 | -0.4% | 0.00% | +33.3% |
| Q2 2023 | $74,469 | +13.1% | 1,815 | -1.5% | 0.00% | 0.0% |
| Q1 2023 | $65,833 | -5.7% | 1,842 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $69,799 | -13.8% | 1,848 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $81,000 | -17.3% | 1,838 | -30.7% | 0.00% | 0.0% |
| Q2 2022 | $98,000 | -4.9% | 2,651 | -5.0% | 0.00% | 0.0% |
| Q1 2022 | $103,000 | +19.8% | 2,791 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $86,000 | +104.8% | 2,804 | +125.9% | 0.00% | +50.0% |
| Q3 2021 | $42,000 | +20.0% | 1,241 | +43.0% | 0.00% | 0.0% |
| Q2 2021 | $35,000 | – | 868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |